|
2021
|
Invention
|
Colon cleansing compositions and method of use. b) 10 to 200 g per litre polyethylene glycol.
... |
|
2020
|
Invention
|
Colonoscopy—preparation. The invention provides a colon cleansing solution comprising: a) 300 to ... |
|
|
G/S
|
Pharmaceutical products for inducing child birth |
|
|
G/S
|
Pharmaceutical preparations for inducing childbirth. |
|
|
Invention
|
Colonoscopy-preparation. The invention provides a colon cleansing solution comprising: a) 300 to ... |
|
2018
|
Invention
|
Compositions.
The invention provides a colon cleansing solution comprising:
a) 300 to 800 m... |
|
|
Invention
|
Compounds useful as ccr9 modulators.
The present invention relates to compounds useful as CCR9 m... |
|
2017
|
Invention
|
Formulations comprising polyethylene glycol.
The present invention concerns a solid formulation ... |
|
|
Invention
|
Colon cleansing compositions and methods of use. b) 10 to 200 g per litre polyethylene glycol.
... |
|
|
Invention
|
Compositions. The invention provides a colon cleansing solution comprising:
a) 300 to 800 mmol p... |
|
|
Invention
|
Colonoscopy - preparation. The invention provides a colon cleansing solution comprising: a) 300 t... |
|
2016
|
Invention
|
Compositions. b) 10 to 200 g per liter polyethylene glycol.
The invention also provides method... |
|
|
Invention
|
Peg or peg block copolymer for treating colorectal cancer.
The present invention relates to meth... |
|
2015
|
Invention
|
Compositions.
The invention provides a colon cleansing solution comprising:
The invention prov... |
|
|
Invention
|
Compositions. b) 10 to 200 g per litre polyethylene glycol.
The invention also provides method... |
|
|
Invention
|
Method of cleansing the colon. The present invention relates to colon cleansing solutions, compos... |
|
|
Invention
|
Method of cleansing the colon. The invention provides a method of cleansing the colon of a subjec... |
|
2014
|
Invention
|
Benzene sulfonamides as ccr9 inhibitors.
The present invention relates to compounds useful as CC... |
|
|
Invention
|
Compounds useful as ccr9 modulators. The present invention relates to compounds useful as CCR9 mo... |
|
|
Invention
|
Benzene sulfonamides as ccr9 inhibitors. The present invention relates to compounds useful as CCR... |
|
|
Invention
|
Solid preparation.
The present invention provides a solid preparation formulation containing a p... |
|
|
Invention
|
Solutions comprising polyethylene glycol and electrolytes. A solution in water comprising the fol... |
|
2013
|
Invention
|
Compositions comprising polyethylene glycol in the therapy of head and neck squamous cell carcino... |
|
|
Invention
|
Compositions comprising polyethylene glycol for use in the therapy of egfr-dependent cancers.. Di... |
|
|
Invention
|
Compositions comprising peg and ascorbate. The invention provides acolon cleansing solutioncompri... |
|
|
Invention
|
Colon cleansing composition comprising ascorbate and peg. The invention provides acolon cleansing... |
|
|
Invention
|
Colon cleansing composition comprising ascorbate and peg. The invention provides a colon cleansin... |
|
2012
|
Invention
|
Compositions comprising cetilistat. The present invention relates to compositions comprising ceti... |
|
|
Invention
|
Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine. 1R,2S-Methoxamine ... |
|
|
Invention
|
Prognostic method. A method of determining the functional activity of the MRP2 and/or MRP3 efflux... |
|
|
Invention
|
Low volume colon cleansing solutions comprising ascorbate and polyethylene glycol. The invention ... |
|
|
Invention
|
Enema compositions. The invention provides an aqueous liquid enema composition having a measured ... |
|
|
Invention
|
Improvements in and relating to compositions. The present invention concerns aqueous solutions co... |
|
2011
|
Invention
|
Peg or peg block copolymers for treating colorectal cancer.
The present invention relates to met... |
|
|
Invention
|
Formulations comprising polyethylene glycol. The present invention concerns a solid formulation f... |
|
|
Invention
|
Peg or peg block copolymers for treating colorectal cancer. The present invention relates to meth... |
|
|
Invention
|
Compounds. 1,1-dioxo-1-ursodeoxycholamino-tetrahydrothiopyran-4-carboxylic acid, and salts, ester... |
|
|
Invention
|
Compositions.
The present invention concerns solid compressed oral pharmaceutical compositions c... |
|
|
Invention
|
Compositions. The present invention concerns solid compressed oral pharmaceutical compositions co... |
|
2010
|
Invention
|
2-oxy-benzoxazinone derivatives for the treatment of obesity. The use of a compound comprising fo... |
|
|
Invention
|
Solutions comprising polyethylene glycol and electrolytes.
The invention provides a solution in ... |
|
|
Invention
|
Crystal of a benzoxazinone compound. Disclosed is a crystal of 2-(hexadecyloxy)-6-methyl-4H-3,1-b... |
|
|
Invention
|
Process for the preparation of 5-/6-nitrofluorescein.
A process for the preparation of a mixture... |
|
|
Invention
|
Process for the preparation of cholyl-l-lysine.
A process for the preparation of cholyl-L-lysine... |
|
2004
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders including obesi... |
